Abstract:Background: Special AT-rich sequence binding protein 1 (SATB1) is a chromatin organizer and transcriptional regulator which regulate numerous cellular processes through effects on multiple gene expression. SATB1 is associated with drug resistance in several cancers. Whether SATB1 involves radiation resistance in nasopharyngeal carcinoma (NPC) and underlying mechanism of SATB1 to participate in chemoradiotherapy resistance in NPC have not been elaborated.Methods: Chemoradioresistant NPC cell lines 5-8F/DDP (cisplatin) and 5-8F/R (radiation) were developed from 5-8F cell line. The expressions of SATB1, MMP-9 and EMT markers (Vimentin and E-cadherin) in these cell lines were examined by reverse transcription-quantitative (RT-q) PCR and western blot (WB) analysis. Cell viabilities of 5-8F/DDP treated with various concentrations of DDP and 5-8F/R irradiated with various doses of X-ray at the indicated time were investigated by MTT test. SATB1 was silenced in 5-8F/DDP and 5-8F/R cells by short hairpin RNA, and then the expressions of SATB1, MMP-9, Vimentin and E-cadherin were evaluated by RT-qPCR and WB analysis; the abilities of cell proliferation and invasion were assessed using MTT and transwell assays, respectively. Drug and radiation resistance assays were performed after SATB1 knockdown and cell viability was detected by MTT method.Results: SATB1, MMP-9 and Vimentin were markedly upregulated in 5-8F/DDP and 5-8F/R cells compared with 5-8F cell, whereas E-cadherin was obviously downregulated. 5-8F/DDP and 5-8F/R cells displayed drug and radiation resistance to DDP or X-irradiation, respectively, while DDP or X-irradiation inhibited 5-8F cell viability in a time- and dose-dependent manner. Subsequently, knockdown of SATB1 resulted in decreased MMP-9 and Vimentin expression and increased E-cadherin expression in 5-8F/DDP and 5-8F/R. Furthermore, silencing of SATB1 suppressed proliferative and invasive abilities of 5-8F/DDP and 5-8F/R cells. Additionally, SATB1 knockdown reduced drug resistance of 5-8F/DDP cell to DDP and decreased radiation resistance of 5-8F/R cell to X-ray.Conclusion: These results suggest that high expression of SATB1 plays an important role in the malignant behavior of NPC and leads to X-radiation and drug resistance in NPC through promoting EMT process and enhancing MMP-9 expression. SATB1 may be a promising therapeutic target for aggressive and chemoradiation resistant NPC.

Nuclear matrix attachment region binding protein SATB1 up-regulates the expression of breast cancer stem cell phenotype CD44+/CD24-

Special AT-rich Sequence-Binding Protein 1 Promotes Cell Growth and Metastasis in Colorectal Cancer.

Overexpression And Involvement Of Special At-Rich Sequence Binding Protein 1 In Multidrug Resistance In Human Breast Carcinoma Cells

Expression of SATB1 Promotes the Growth and Metastasis of Colorectal Cancer

Molecular Mechanism of Regulating Expression of SATB1

SATB1 is Correlated with Progression and Metastasis of Breast Cancers: A Meta-Analysis.

Expression of SATB1 in breast cancer and its relationship with clinicopathological features

Long Noncoding RNA SATB1-AS1 Contributes to the Chemotherapy Resistance Through the Microrna-580/ 2'-5'-oligoadenylate Synthetase 2 Axis in Acute Myeloid Leukemia.

YAP-Activated SATB2 is a Coactivator of NRF2 That Amplifies Antioxidative Capacity and Promotes Tumor Progression in Renal Cell Carcinoma

Upregulation of SATB1 is Associated with the Development and Progression of Glioma

Cellular transformation of human mammary epithelial cells by SATB2

Oncogenic Role of SATB2 In Vitro: Regulator of Pluripotency, Self-Renewal, and Epithelial–Mesenchymal Transition in Prostate Cancer

Satb1 Expression Is Correlated With Beta-Catenin Associated Epithelial-Mesenchymal Transition In Colorectal Cancer

SATB1 Knockdown Inhibits Proliferation and Invasion and Decreases Chemoradiation Resistance in Nasopharyngeal Carcinoma Cells by Reversing EMT and Suppressing MMP-9

SATB1 mediated tumor colonization and β-catenin nuclear localization are associated with colorectal cancer progression

Silencing SATB1 with Sirna Inhibits the Proliferation and Invasion of Small Cell Lung Cancer Cells

Special AT-rich Sequence Binding Protein 1 Regulates the Multidrug Resistance and Invasion of Human Gastric Cancer Cells.

At-Rich Sequence Binding Protein 1: Contribution to Tumor Progression and Metastasis of Human Ovarian Carcinoma

SATB2 suppresses non-small cell lung cancer invasiveness by G9a

Dysregulation of the miR-34a-SIRT1 axis inhibits breast cancer stemness.

Autophagy Deficiency Induced by SAT1 Potentiates Tumor Progression in Triple-Negative Breast Cancer